These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9889060)

  • 1. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
    Zervos EE; Shafii AE; Rosemurgy AS
    J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
    Zervos EE; Shafii AE; Haq M; Rosemurgy AS
    J Surg Res; 1999 Jun; 84(2):162-7. PubMed ID: 10357914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
    Zervos EE; Norman JG; Gower WR; Franz MG; Rosemurgy AS
    J Surg Res; 1997 May; 69(2):367-71. PubMed ID: 9224409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs.
    Haq M; Shaeii AE; Zervos EE; Rosemurgy AS
    Int J Surg Investig; 2000; 1(6):459-65. PubMed ID: 11729853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA; Johnson MD; Bone EA; Dickson RB
    Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line.
    Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ
    J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
    Matsuyama Y; Takao S; Aikou T
    J Surg Oncol; 2002 Jun; 80(2):105-10. PubMed ID: 12173379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
    Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
    Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20.
    Bu W; Tang ZY; Sun FX; Ye SL; Liu KD; Xue Q; Chen J; Gao DM
    Hepatogastroenterology; 1998; 45(22):1056-61. PubMed ID: 9756006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
    Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
    Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.
    Haq M; Shafii A; Zervos EE; Rosemurgy AS
    Cancer Res; 2000 Jun; 60(12):3207-11. PubMed ID: 10866312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
    Wang X; Fu X; Brown PD; Crimmin MJ; Hoffman RM
    Cancer Res; 1994 Sep; 54(17):4726-8. PubMed ID: 8062271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
    Williams RN; Parsons SL; Morris TM; Rowlands BJ; Watson SA
    Eur J Surg Oncol; 2005 Nov; 31(9):1042-50. PubMed ID: 15993560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
    Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
    Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
    J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.